Edavettal Suzanne C, Carrick Kevin, Shah Ruchir R, Pedersen Lars C, Tropsha Alexander, Pope R Marshall, Liu Jian
Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Biochemistry. 2004 Apr 27;43(16):4680-8. doi: 10.1021/bi0499112.
The 3-O-sulfation of glucosamine by heparan sulfate 3-O-sulfotransferase-1 (3-OST-1) is a key modification step during the biosynthesis of anticoagulant heparan sulfate (HS). In this paper, we present evidence of a conformational change that occurs in 3-OST-1 upon binding to heparan sulfate. The intrinsic fluorescence of 3-OST-1 was increased in the presence of HS, suggesting a conformational change. This apparent conformational change was further investigated using differential chemical modification of 3-OST-1 to measure the solvent accessibility of the lysine residues. 3-OST-1 was treated with acetic anhydride in either the presence or absence of HS using both acetic anhydride and hexadeuterioacetic anhydride under nondenaturing and denaturing conditions, respectively. The relative reactivity of the lysine residues to acetylation and [2H] acetylation in the presence or absence of HS was analyzed by measuring the ratio of acetylated and deuterioacetylated peptides using matrix-assisted laser desorption ionization mass spectrometry. The solvent accessibilities of the lysine residues were altered differentially depending on their location. In particular, we observed a group of lysine residues in the C-terminus of 3-OST-1 that become more solvent accessible when 3-OST-1 binds to HS. This observation indicates that a conformational change could be occurring during substrate binding. A truncated mutant of 3-OST-1 that lacked this C-terminal region was expressed and found to exhibit a 200-fold reduction in sulfotransferase activity. The results from this study will contribute to our understanding of the interactions between 3-OSTs and HS.
硫酸乙酰肝素3 - O - 磺基转移酶 - 1(3 - OST - 1)对葡糖胺进行3 - O - 硫酸化是抗凝硫酸乙酰肝素(HS)生物合成过程中的关键修饰步骤。在本文中,我们提供了证据表明3 - OST - 1与硫酸乙酰肝素结合后会发生构象变化。在HS存在的情况下,3 - OST - 1的固有荧光增强,表明发生了构象变化。使用3 - OST - 1的差异化学修饰来测量赖氨酸残基的溶剂可及性,进一步研究了这种明显的构象变化。分别在非变性和变性条件下,使用乙酸酐和十六氘代乙酸酐,在有或无HS的情况下用乙酸酐处理3 - OST - 1。通过使用基质辅助激光解吸电离质谱法测量乙酰化和氘代乙酰化肽段的比例,分析有或无HS时赖氨酸残基对乙酰化和[2H]乙酰化的相对反应性。赖氨酸残基的溶剂可及性因其位置不同而有差异地改变。特别是,我们观察到3 - OST - 1 C末端的一组赖氨酸残基在3 - OST - 1与HS结合时变得更易被溶剂接触。这一观察结果表明在底物结合过程中可能发生了构象变化。表达了一个缺少该C末端区域的3 - OST - 1截短突变体,发现其磺基转移酶活性降低了200倍。这项研究的结果将有助于我们理解3 - OST与HS之间的相互作用。